09.08.10
AMRI has appointed the following members to its sales leadership team:
Dr. Mark Sawicki has been promoted to vice president of business development for Europe, Christopher Conway has been promoted to senior director of business development for North American Discovery Services, and Angie Urdanoff has been promoted to senior director, sales operations.
Dr. Sawicki will drive the expansion and focus of AMRI’s European sales division and promote the company’s global scientific services, including drug discovery, development/small scale manufacturing and large-scale manufacturing. Previously, he was responsible for sales activities for AMRI discovery services in North America and Europe as senior director of business development. Dr. Sawicki joined the company in 2004 as director of business development.
Mr. Conway will lead sales activities in North America to promote the company’s drug discovery services including the company’s global integrated drug discovery platform. Prior to joining AMRI, Mr. Conway held sales positions of increasing responsibility at Johnson & Johnson, including serving as district manager for Johnson & Johnson’s Ortho-McNeil Neurologics Division. Mr. Conway joined the company in 2008 as manager of business development.
Ms. Urdanoff will have increased oversight for driving the company’s global sales operations efforts. Before joining the company, Ms. Urdanoff worked for Pitney Bowes Business Insight as managing director of Americas sales operations. Prior to that, she served as product and manufacturing manager for GE Silicones. She joined AMRI in 2009 as director of sales operations.
“We are pleased to announce the promotions of these individuals who have made significant contributions to AMRI’s sales organization,” said chairman, chief executive officer and president Thomas E. D’Ambra, Ph.D. “As AMRI continues to add locations and expand the breadth of its products and services, we are also increasing the scope of our sales activities with the goal of expanding our market share. We are proud to recognize the contributions of these key individuals, congratulate them on this important step, and wish them great success in their new roles.”
Dr. Mark Sawicki has been promoted to vice president of business development for Europe, Christopher Conway has been promoted to senior director of business development for North American Discovery Services, and Angie Urdanoff has been promoted to senior director, sales operations.
Dr. Sawicki will drive the expansion and focus of AMRI’s European sales division and promote the company’s global scientific services, including drug discovery, development/small scale manufacturing and large-scale manufacturing. Previously, he was responsible for sales activities for AMRI discovery services in North America and Europe as senior director of business development. Dr. Sawicki joined the company in 2004 as director of business development.
Mr. Conway will lead sales activities in North America to promote the company’s drug discovery services including the company’s global integrated drug discovery platform. Prior to joining AMRI, Mr. Conway held sales positions of increasing responsibility at Johnson & Johnson, including serving as district manager for Johnson & Johnson’s Ortho-McNeil Neurologics Division. Mr. Conway joined the company in 2008 as manager of business development.
Ms. Urdanoff will have increased oversight for driving the company’s global sales operations efforts. Before joining the company, Ms. Urdanoff worked for Pitney Bowes Business Insight as managing director of Americas sales operations. Prior to that, she served as product and manufacturing manager for GE Silicones. She joined AMRI in 2009 as director of sales operations.
“We are pleased to announce the promotions of these individuals who have made significant contributions to AMRI’s sales organization,” said chairman, chief executive officer and president Thomas E. D’Ambra, Ph.D. “As AMRI continues to add locations and expand the breadth of its products and services, we are also increasing the scope of our sales activities with the goal of expanding our market share. We are proud to recognize the contributions of these key individuals, congratulate them on this important step, and wish them great success in their new roles.”
